30 Years of pharmaceutical cost-utility analyses: Growth, diversity and methodological improvement

PharmacoEconomics

Volumn 27, Issue 10, 2009, Pages 861-872

  Neumann, Peter J ^a   Fang, Chi Hui ^a   Cohen, Joshua T ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DRUG INDUSTRY; MEDICAL INFORMATION; PRIORITY JOURNAL;

COST-BENEFIT ANALYSIS; LOGISTIC MODELS; PEER REVIEW, RESEARCH; PERIODICALS AS TOPIC; PHARMACEUTICAL PREPARATIONS; QUALITY-ADJUSTED LIFE YEARS; RESEARCH; RESEARCH SUPPORT AS TOPIC;

EID: 70349925974     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11312720-000000000-00000     Document Type: Article

References (21)

1. Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996
2. Neumann PJ, Greenberg D, Olchanski NV, et al. Growth and quality of the cost-utility literature, 1976-2001. Value Health 2005; 8 (1): 3-9
3. Task Force on Principles for Economic Analysis of Health Care Technology. Economic analysis of health care technology: a report on principles. Intern Med 1995; 123: 61-70
4. Drummond MF, Jefferson TO, on behalf of the BMJ Economic Evaluation Working Party. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996; 313 (7052): 275-283
5. Drummond MF, RichardsonWS, O'Brien BJ, et al., on behalf of the Evidence-Based Medicine Working Group. Users' guides to themedical literature: XIII.How to use an article on economic analysis of clinical practice: A. Are the results of the study valid? JAMA 1997; 277 (19): 1552-1557
6. Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. New York: Oxford University Press, 1997
7. Menon D, Schubert F, Torrance GW. Canada's new guidelines for the economic evaluation of pharmaceuticals. Med Care 1996; 34 (12 Suppl.): DS77-86 (Pubitemid 126727850)
8. O'Brien BJ, Heyland D, Richardson WS, et al., on behalf of the Evidence-Based Medicine Working Group. Users' guides to the medical literature: XIII. How to use an article on economic analysis of clinical practice: B. What are the results and will they help me in caring for my patients? JAMA 1997; 277 (22): 1802-1806
9. Stone PW, Teutsch S, Chapman RH, et al. Cost-utility analyses of clinical preventive services: published ratios, 1976-1997. Am J Prev Med 2000; 19 (1): 15-23
10. Bell CM, Urbach DR, Ray JG, et al. Bias in published cost effectiveness studies: systematic review. BMJ 2006; 332 (7543): 699-703
11. Catlin A, Cowan C, Hartman M, et al., on behalf of the National Health Expenditure Accounts Team. National health spending in 2006: a year of change for prescription drugs. Health Aff 2008 Jan-Feb; 27 (1): 14-29
12. Neumann PJ, Rosen AB, Greenberg D, et al. Can we better prioritize resources for cost-utility research? Med Decis Making 2005 Jul-Aug; 25 (4): 429-436
13. The AMCP format for formulary submissions, version 2.1. 2005 Apr [online]. Available from URL: http://www.amcp. org/amcp.ark?p=0F6E1295 [Accessed 2009 Aug 4]
14. Siegel JE,Weinstein MC, Russell LB, et al., on behalf of the Panel on Cost-Effectiveness in Health and Medicine. Recommendations for reporting cost-effectiveness analyses. JAMA 1996; 276 (16): 1339-1341
15. Neumann PJ, Sandberg EA, Bell CM, et al. Are pharmaceuticals cost-effective? A review of the evidence. Health Aff (Millwood) 2000; 19 (2): 92-109
16. Rosen AB, Greenberg D, Stone PW, et al. Quality of abstracts of papers reporting original cost-effectiveness analyses. Med Decis Making 2005 Jul-Aug; 25 (4): 424-428
17. Gonzalez-Perez JG, Vale L, Stearns SC, et al. Hemodialysis for end-stage renal disease: a cost-effectiveness analysis of treatment-options. Int J Technol Assess Health Care 2005; 21 (1): 32-39 (Pubitemid 40229366)
18. Patel A, Knapp M, Evans A, et al. Training care givers of stroke patients: economic evaluation. BMJ 2004 May 8; 328 (7448): 1102 (Pubitemid 38608438)
19. Goodacre S, Nicholl J, Dixon S, et al. Randomised controlled trial and economic evaluation of a chest pain observation unit compared with routine care. BMJ 2004; 328 (7434): 254 (Pubitemid 38168133)
20. Cohen JT, Neumann PJ, Weinstein MC. Does preventive care save money? Health economics and the presidential candidates. N Engl J Med 2008 Feb 14; 358 (7): 661-663
21. Arguedas MR, Heudebert GR, Fallon MB, et al. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States. Am J Gastroenterol 2002; 97 (3): 721-728 (Pubitemid 34245904)